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CARDIAC TRANSPLANTATION IN THE RAT 
I. THE EFFECT OF HISTOCOMPATIBILITY DIFFERENCES ON GRAFT ARTERIOSCLEROSIS! 
DONALD V. CRAMER2.3 SHIQUANG QIAN,4 Jo HARNAHA,2 FRANCES A. CHAPMAN; 
LARRY W. ESTES,2 THOMAS E. STARZL,4 AND LEONARD MAKOWKA4 
Department., of Pathology and Surgery. University of Pittsburgh School of Medicine. Pittsburgh. Pennsylvania 15261 
The development of arteriosclerosis is the most serious 
and common complication in long-term survivors of car-
diac transplantation. We have used a variety of inbred 
rat strains with selected histocompatibility differences 
to examine the influence of prolonged, mild rejection 
reactions on the development of pathological changes in 
long-term cardiac allografts. Heterotopic cardiac allo-
grafts were exchanged between rat strains that differed 
for MHC class I (RT1.A and/or RT1.E) antigens or 
groups of minor, non-MHC antigens in MHC-compatible 
congenic combinations. Our results demonstrate that in 
strain combinations in which the allograft reaction is 
mild and prolonged, the donor hearts exhibit pathologi-
cal changes that include a diffuse, interstitial myocar-
dial fibrosis, perivascular fibrosis, and intimal prolif-
eration in arteries of the graft myocardium. The lesions 
were less prominent in animals with more active rejec-
tion and infrequent in strains that differ for class I 
histocompatibility antigens or syngeneic controls. These 
results suggest that the comparable pathological changes 
seen in long-term human cardiac survivors may reflect 
low-level, persistent allograft reactions rather than fac-
tors associated with graft anoxia or effects of immuno-
therapy to prevent graft rejection. 
Cardiac transplantation has become an important and effec-
tive therapeutic alternative for patients with terminal heart 
disease. The inclusion of cyclosporine as part of the immuno-
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suppressive regimen for patients following cardiac transplan-
tation has resulted in a reduction in the severity of rejection 
episodes and infectious complications, and has improved pa-
tient survival to greater than 80% in the first year after trans-
plantation (1). With the prolonged survival of cardiac allo-
grafts, however, has come the recognition of important graft-
related complications in long-term survivors. 
The most frequent and important complication of cardiac 
allografts for patients who survive the first postoperative year 
is the appearance of an accelerated arteriosclerosis in the 
coronary arteries of the donor heart (2). The arteriosclerosis 
consists of a concentric proliferation of the intima that gradu-
ally reduces peripheral blood flow and frequently produces 
myocardial infarction secondary to occlusion of the vessels. At 
five years after grafting the incidence of graft arteriosclerosis 
is approximately 50%. 
The appearance of similar vascular lesions has been reported 
in experimental animals after cardiac allografting. In the dog, 
proliferative intimal lesions were observed in the coronary 
arteries of orthotopic cardiac allografts that survived for greater 
than three months (3), suggesting that the lesions were due to 
chronic rejection of the graft following treatment of the recip-
ients with immunosuppressive agents. Similar vascular lesions 
have been observed in rabbits (4, 5) and in xenografts between 
subhuman primates (6). 
Rat heterotopic cardiac allografts have been shown to develop 
vascular intimal proliferation if the grafts survive for sufficient 
periods (7, 8). Cardiac grafts exchanged between strains of rats 
compatible for their class I (RT1.A) histocompatibility antigens 
developed proliferation of collagen-producing myointimal cells 
after graft survival of at least 30 days (7). The donor/recipient 
strain combinations used for these studies presumably differed 
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Dfu~ JJlinor non-MHC histocompatibility loci and perhaps other 
r. within the MHC, as evidenced by brisk first-set skin graft 
f~l tion (10-15 days) and variable cardiac rejection times (9-~daysFK Reduction in the severity of the allograft reaction 
b treatment of the recipients with azathioprine (12 mg/kg/ ;y) was associated with a concomitant reduction in the degree 
of intimal proliferation (4). Similar results were obtained with 
heterotopic cardiac grafts exchanged between ACI donors and 
(LEwxBN)F1 recipients (8). This donor/recipient strain com-
<it;IDation is mismatched for MHC and non-MHC histocompat-
ibility antigens, and grafts that survived 20 to 50 days developed 
arteriosclerosis. The number and severity of the arterial lesions 
increased when the rejection process was suppressed by treat-
JJlen t of the recipients with CsA. The degree of vascular involve-
ment did not appear to be related to the severity of the rejection. 
Previous reports of the toxic effects of CsA on graft arteries (9, 
10) and the appearance of vascular lesions in the isograft 
controls, however, complicated the interpretation of the data. 
We have recently conducted a series of experiments in which 
heterotopic cardiac grafts were exchanged between strains of 
fats that differ for defined MHC and non-MHC histocompati-
bility differences. We have previously demonstrated that in-
compatibility for selected class I MHC and non-MHC histo-
compatibility loci may be associated with long-term survival of 
cardiac (II, 12), bone marrow (13), and liver (14) allografts. 
The donor/recipient combinations used in these studies were 
selected for allogeneic differences that would provide for pro-
longed cardiac allograft survival in the absence of immuno-
suppression, and provide the opportunity to establish the im-
portance of histocompatibility differences on the pathogenesis 
of the cardiac lesions. Our results demonstrate that prolonged 
survival of cardiac grafts between donor and recipient combi-
nations with weak allogeneic incompatibilities, are associated 
with the development of arteriosclerosis, diffuse myocardial 
fibrosis, and perivascular fibrosis. 
MATERIALS AND METHODS 
Animals. Adult rats (10-16 weeks of age), bred in our colony at the 
University of Pittsburgh School of Medicine, were used in this study. 
The strains of rats and their genetic characterization are presented in 
Table 1. The rats were housed under conventional conditions and fed 
rat chow (Wayne Lab-Blox F-6, Chicago, IL), and tap water ad libitum. 
Heterotopic cardiac grafts. Intraabdominal heterotopic cardiac graft-
ing was performed using a modification of the techniques described by 
Ono and Lindsey (15). The donor animals were anesthetized with 
sodium pentobarbital (40 mglkg intraperitoneally) and maintained on 
methoxyflurane via inhalation. The vena cavae and pulmonary veins 
were ligated with 5-0 silk, and the pulmonary artery and aorta tran-
sected 2-3 mm above their origins in the heart. After perfusion of the 
ventricles and atria with lactated Ringer's solution (containing 200 UI 
ml of heparin), the heart was placed in a saline bath at 4'C. Recipient 
animals were anesthetized with pentobarbital, a midline incision made, 
and the great abdominal vessels dissected free from the left renal vein 
to the bifurcation. The graft was implanted in the abdominal cavity 
with both anastomoses done in a running end-to-side fashion with 10-
o Novafil on a TE-I0 needle. Operative times ranged from 30-45 min, 
with a success rate of approximately 90%. The grafts were evaluated 
for function by abdominal palpation and all grafts were removed 90 
days postoperatively. At removal, the grafts were perfused with 2% 
glutaraldehyde in sodium cacodylate buffer (0.125 M Na cacodylate, 
0.75 M sucrose at pH 7.5). The hearts were fixed in solution for 24 hr 
and then stored in buffer prior to processing. 
Histology. All grafts were examined histologically following section-
ing and staining with hematoxylin and eosin, Masson's trichrome, and 
TABLE 1. Genetic incompatibilities for donor and recipient cardiac 
allografts 
Disparity 
Group Donor Recipient Non-RTI (donor strain 
RTI non-MHC allogeneic 
differences) 
1 DA DA 
2 DA DA.II(Bl) RT1.A" 
3 DA.1I(BI) (DAxBN)F1 RT1.Eu 
4 DA.lI(BI) DA RT1.An+Eu 
5 DA.IN(BN) BN DA 
6 BN DA.IN(BN) BN 
7 BN.IA(DA) DA BN 
Use some other symbol. Small letter designations imply an RTI 
haplotype designation. (i.e. RTl", RTlb, etc.) 
Berhoffs elastic stains. Selected specimens were embedded in epon-
araldite, and I-pm sections used for examination with the light micro-
scope. Ultrathin sections were stained with uranyl acetate and lead 
citrate and examined with a Phillips 300 transmission electron micro-
scope. Histologic findings were scored blindly by one pathologist for 
mononuclear inflammatory infiltrates ofthe myocardium, perivascular 
inflammation, and fibrosis and arteriosclerosis of myocardial vessels. 
All lesions were graded for severity using a scale of 0 (none), 1 + (trace), 
2+ (mild), 3+ (moderate), and 4+ (severe). The severity of the arteri-
osclerosis lesions was classified by the extent of the lesions and repre-
sented changes that were trace-to-mild in one vessel (1+), moderate in 
one or two vessels (2+), mild-to-moderate in several vessels (3+), or 
severe in several vessels (4+). 
RESULTS 
Graft survival. The genetic incompatibilities for the recipi-
ent/donor strain combinations are presented in Table 1. Each 
of these combinations represents allogeneic differences that do 
not stimulate acute graft rejection, and all of the hearts included 
in this study were viable at 90 days posttransplantation. These 
survival times are in general agreement with the experimental 
results of cardiac allografting from a variety of laboratories 
(16). Incompatibility for MHC class I antigens in the rat is a 
weak stimulus for rejection, and survival times are variable and 
usually prolonged. In these experiments, the strains selected 
for grafting expressed RT1.A and/or RT1.E class I histocom-
patibility antigens that did not stimulate acute rejection of the 
donor hearts. 
Histopathologic findings. General: The pathologic changes 
observed in the cardiac allografts ranged from none to lesions 
consistent with prolonged, moderate allograft rejection. In gen-
eral, the syngeneic controls and strain combinations with MHC 
class I incompatibilities displayed minimal changes, while the 
MHC compatible, non-MHC incompatible combinations had 
lesions consistent with mild-to-moderately severe allograft 
rejection (Table 2)_ Two types of histopathologic changes were 
seen in both control and test animals that were not clearly 
related to the allograft reaction. The first was the presence of 
focal inflammatory infiltrates and areas of fibrosis in the sub-
endothelial and epicardial surfaces of the graft (Table 2). The 
intensity of these reactions was similar between groups and 
they were considered to represent tissue reactions to the graft-
ing procedure. The second type of pathologic change seen in 
both the control and test groups was the appearance of focal, 
transmural areas of myocardial atrophy and fibrosis in the left 
and/or right ventricles. These lesions were interpreted to rep-
resent areas of infarction with subsequent healing and fibrosis. 
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The evaluation of the vascular and myocardial lesions asso-
ciated with the allograft reaction excluded areas containing 
either type of these two lesions. Two animals, one in group 4 
and one in group 6, had extensive areas of infarction and were 
excluded from the study. 
Syngeneic controls: The pathologic changes seen in the syn-
geneic grafts exchanged between DA strain animals consisted 
of mild-to-moderate focal inflammatory lesions with fibrosis in 
the epicardium and in subendothelial locations in the left and 
right ventricles. These lesions were consistently present in all 
the control and test groups (Table 2) and were considered to 
represent changes secondary to the grafting procedures. None 
ofthe control animals exhibited histologic evidence of myocar-
dial or perivascular fibrosis or diffuse inflammation of the 
myocardium. One animal had focal areas of infarction in both 
the left and right ventricle. 
Class I MHC incompatibilities: Three of the donor/recipient 
strain combinations differ for either RTl.A and/or RTl.E class 
I histocompatibility antigens. These histocompatibility differ-
ences do not stimulate consistent allograft reactions, and the 
histologic changes present in cardiac allografts transplanted 
between these strains were mild and variable 90 days posttrans-
plantation. The animals in group 3 differed for a class I-like 
MHC antigen (RTl.E") that has not been associated with 
evidence of allograft rejection in tissues other than skin 
(J 3). The histological appearance of the grafts exchanged be-
tween animals in this group did not differ from those seen in 
the control group and were consistent with the inability of this 
TABLE 2. Histopathological lesions in donor hearts following allografting across defined genetic incompatibilities· 
Group Donor Recipient n \'IP PVF MFD MID MFF MIF VAS 
DA DA 5 0 0 0 0 1.2 1.4 0 
2 DA DA.lI 10 0.9 1.2 0 0.4 1.9 1.7 0 
:1 DA.lI (DAxBN)F, 8 0 0 0 0 1.8 1.1 0 
4 DA.ll DA 9 0 0.2 0.3 0.2 1.7 1.7 0 
5 DA.1N BN 11 1.1 1.9 2.5 2.9 1.8 2.1 1.2 
6 BN DA.1N 12 0.9 1.9 0.9 0.4 1.8 1.4 0.1 
7 BN.1A DA 6 1.3 3.0 3.3 2.0 1.7 2.3 0.3 
a Lesions are graded as described in the text, and the scores represent the mean grade for the animals within the group. VIP: vascular intimal 
proliferation; PVF: perivascular fibrosis; MFD: myocardial fibrosis, diffuse; MID: myocardial inflammation, diffuse; MFF: myocardial fibrosis, 
focal; MIF: myocardial inflammation, focal; VAS: vasculitis. 
FIGURE 1. Histopathological changes in cardiac graft consisting of 
perivascular fibrosis, mild inflammatory cell infiltration, and fibrosis 
(A,B). Patchy areas of interstitial fibrosis with minimal numbers of 
.. ... fit· 
. . 
inflammatory cells were also present (C,D). All sections were stained 
with hematoxylin and eosin (A: x300; B: X750; C: X300; D: X750). 
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C antigen to stimulate rejection of the heart. In group 4 rd~ and recipient animals differed for the RT1.N and 
~:p class I antigens. In this group, occasional animals had 
"~d ce of chronic rejection with minimal-to-mild diffuse myo-~nl fibrosis, perivascular fibrosis, and myocardial inflam-
':n. Only two animals in group 4 had any evidence of ~:se fibrosis of the myocardium, and two animals exhibited 
dl lS of healed infarcts. The donor/recipient strain combina-~a of DA to DA.lI (group 2) differed for the RT1.A" class I 
til~genI and approximately 50% of the animals had evidence 
~ JDild, prolonged allograft reactions. These consisted of a 
i1d, diffuse interstitial infiltration of the myocardium (4 ani-
rn als), mild-to-moderate perivascular fibrosis (5 animals) and 
~ld_to-moderate intimal proliferation (5 animals). 
FIGURE 2. Concentric myointimal proliferation in medium-to-large 
myocardial arteries with narrowing of the lumen (A) and irregular focal 
areas of proliferation (B,C). All sections were stained with hematoxylin 
and eosin (A: x300; B: X750; C: X1200). 
Non-MHC incompatibilities: Three donor/recipient strain 
combinations differed for non-MHC histocompatibility anti-
gens. The combination in which the non-MHC target antigens 
were contributed by the BN strain (group 6) had histologic 
changes that were similar in intensity and character to those 
described earlier for group 2 (RT1.A-incompatible). In the 
group 6 combination there was the appearance of trace amounts 
of interstitial fibrosis in 8 of 10 animals and a distinct mild-to-
moderate level of perivascular proliferation in 9 animals. 
The remaining two non-MHC strain combinations had le-
sions that were more advanced and intense. The animals in 
group 7 all exhibited a moderate-to-severe, diffuse fibrosis of 
the myocardium. The fibrosis was associated with a mild, 
diffuse mononuclear inflammatory infiltrate and moderate lev-
els of perivascular fibrosis (Fig. 1). The inflammatory infiltrate 
consisted primarily of small lymphocytes and macrophages. 
Of particular interest was the appearance of mild-to-moder-
ate levels of intimal proliferation in several medium-to-Iarge 
intra myocardial arteries (Fig. 2). The intimal lesions consisted 
of concentric fibrointimal cellular proliferation with luminal 
narrowing and partial occlusion of the vessels. The lesions were 
similar in extent and severity in groups 2 (RTl.A incompatible) 
and 5, 6 and 7 (non-MHC incompatible). The early lesions 
consisted of irregular endothelial proliferation, alterations in 
the internal elastic membrane, and infiltration of the vascular 
media with inflammatory cells, primarily macrophages (Figs. 3 
and 4). The internal elastic membrane stained intensely with 
toluidine blue and was irregular in shape and discontinuous. 
The lesions seen in group 5 consisted of intimal proliferation, 
perivascular fibrosis, and diffuse myocardial fibrotic lesions 
similar to those seen in group 7. The character of these lesions 
was modified, however, by the appearance of a more severe 
inflammatory infiltrate of the myocardium. This inflammatory 
infiltrate was present in all 10 animals (moderate-to-severe in 
8) and obscured the interstitial and perivascular fibrosis. Two 
animals in each of two groups (5 and 6) had focal areas of 
healed infarcts. 
DISCUSSION 
The appearance of arteriosclerosis in the coronary vessels of 
a cardiac allograft is a common and serious complication of 
heart transplantation (2). The vascular lesion tends to be 
diffuse, involving the more distal myocardial vessels and lead-
ing to the gradual occlusion of the vessels. In patients with 
cardiac allografts, significant coronary artery disease is present 
in approximately 50% of grafts that survive .5 years. The 
occlusion of coronary vessels by intimal proliferation is a com-
mon and sudden cause of death in graft recipients. 
The pathogenesis of the coronary artery disease in cardiac 
allografts is not known. In experimental animals, the appear-
ance of arteriosclerosis of myocardial vessels is associated with 
exchange of allogeneic grafts. Grafts exchanged between genet-
ically identical (syngeneic) animals are generally free of vas-
cular and myocardial lesions, demonstrating that the appear-
ance of the lesions is not the result of the grafting procedure. 
When grafts are exchanged across allogeneic barriers, the ar-
terial lesions appear, either caused by the recognition and 
rejection of the foreign graft or secondary to immunosuppres-
sion of the recipient to prevent graft rejection. In most studies, 
the prospective exchange of cardiac allografts has been con-
ducted across allogeneic combinations in which loss ofthe graft 
418 TRANSPLANTATION Vol. 47, No.3 
4'/,#4 ••• 
FIGURE 3. Early arterial lesions consisting of endothelial proliferation, disruption of prominently stained basement membrane (A,B,C), and 
infiltration of the vessel wall with macrophages (D). All sections stained with toluidine blue (A: x750; B: X 1200; C: X3000; D: X3000). 
FIGURE 4. Electron photomicrograph of the vessel illustrated in 
Figure 3. The internal elastic membrane (B) is irregular, electron dense 
and discontinuous. Macrophages (M) are present in the vessel wall and 
a small group of platelets (P) is associated with the endothelial surface 
(x 7300, moderately reduced). 
from acute rejection occurs if the recipient is not treated with 
some form of immunosuppression. Under these conditions it 
has been difficult to establish the influence of immunosuppres-
sion on the development of the vascular lesions. This is partic-
ularly true for CsA, where arteriolar lesions, including intimal 
proliferation, have been associated with immunosuppression of 
renal allograft recipients (9, 10). At least one group of investi-
gators have also suggested that immunosuppression, particu-
larly with CsA, is capable of stimulating the atherosclerosis in 
cardiac grafts (17). 
In the present study we have demonstrated that early arterial 
proliferative lesions, diffuse myocardial fibrosis, and perivas-
cular fibrosis are histopathologic lesions associated with long-
term (90-day) cardiac allografts. Grafting across histocompat-
ibility differences that do not stimulate acute rejection allows 
for prolonged graft survival without immunosuppression and 
provides the opportunity for the emergence of the lesions in 
the donor heart. The type of histocompatibility difference does 
not appear to be important in determining the type of lesions 
present in the graft, as both MHC (class I) and non-MHC 
differences are capable of inducing one or more of the lesions 
described. Moreover, within the group of non-MHC incompat-
ibilities, differences in the degree and character of the patho-
logic changes suggest that the most important feature of the 
disease process may be the strength of the allograft reaction. 
This interpretation of the data would be consistent with the 
results of previous experiments and suggests that the vascular 
changes represent a balance between the strength of the allo-
graft reaction and sufficient time for the histopathological 
changes to appear. 
The mechanism by which allogeneic differences stimulate 
the development of cardiac allograft lesions is unknown. In 
humans it has been suggested that a target for the allograft 
reaction is the vascular endothelium and that antibodies pro· 
duced against endothelial cells (8) or against antigens shared 
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B lymphocytes and the vascular endothelium (19) are re-
by nsib1e for initiating the vascular lesions. In rats, a non-~C endothelial antigen, Eag-I, is capable of stimulating the 
roduction of allospecific antibodies that bind to vascular en-
~theliumI (20) and the antigen has been indirectly associated 
with renal rejection (21). The strains used in these studies 
differ for Eag-I, BN expressing the antigen and the DA and 
J)A.lI strains being negative. The appearance of the vascular 
lesions in groups 2 and 5, where the Eag-I antigen is not 
expressed, however, suggests that this antigen system is not 
the primary target of the allograft reaction. Although the Eag-
1 endothelial antigen system may not be the primary target of 
the allograft reaction, we have demonstrated that cardiac allo-
grafts exchanged across various histocompatibility differences 
may stimulate active immune responses, including antibodies 
against both MHC and non-MHC antigens (I 1). These anti-
bodies were directed against erythrocytic and lymphocytic an-
tigens that may be expressed by the cells of the donor heart 
graft. Antibodies that react with antigens expressed specifically 
in the graft or against antigens shared with other tissues 
represent the most probable mechanism for initiating the vas-
cular damage seen in these studies and is consistent with the 
histological changes observed in the affected vessels. 
In summary, the exchange of heterotopic cardiac allografts 
between rat strains that display weak histocompatibility"differ-
ences has been shown to stimulate the appearance of specific 
histopathological changes in the donor heart. These changes 
include diffuse fibrosis of the myocardium, perivascular fibrosis, 
and the appearance of arteriosclerosis. The arteriosclerosis 
consists of a concentric proliferation of myointimal cells in the 
distal branches of the coronary arteries and is associated with 
mild infiltration of the vessels with inflammatory cells and 
damage to the internal elastic membrane. The extent of the 
donor heart vascular lesions was correlated with the intensity 
of the allograft reaction and was not due to graft damage during 
the surgical procedure or to the administration of immunosup-
pressive agents. 
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